Developmental and species-divergent globin switching are driven by BCL11A
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The contribution of changes in cis-regulatory elements or trans-acting factors to interspecies differences in gene expression is not well understood. The mammalian β-globin loci have served as a model for gene regulation during development. Transgenic mice containing the human β-globin locus, consisting of the linked embryonic (ε), fetal (γ) and adult (β) genes, have been used as a system to investigate the temporal switch from fetal to adult haemoglobin, as occurs in humans. Here we show that the human γ-globin (HBG) genes in these mice behave as murine embryonic globin genes, revealing a limitation of the model and demonstrating that critical differences in the trans-acting milieu have arisen during mammalian evolution. We show that the expression of BCL11A, a repressor of human γ-globin expression identified by genome-wide association studies, differs between mouse and human. Developmental silencing of the mouse embryonic globin and human γ-globin genes fails to occur in mice in the absence of BCL11A. Thus, BCL11A is a critical mediator of species-divergent globin switching. By comparing the ontogeny of β-globin gene regulation in mice and humans, we have shown that alterations in the expression of a trans-acting factor constitute a critical driver of gene expression changes during evolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“BCL11A protein is developmentally regulated and is required to maintain HbF silencing in human adult erythroid cells (4, 5).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Subsequent studies demonstrated that BCL11A, a zinc- fi nger transcription factor, is a bona fi de repressor of HbF expression (4 -7).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to primary human cells, the baseline expression of transgenic γ -globin gene in adult β -YAC mice is far lower than anticipated from normal individuals, possibly due to differences in the transacting environment between mouse and human (5).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [5]
In the citing paper
“This is consistent with a more stringent developmental repression within the murine environment (Sankaran et al., 2009).”
From Reactivation of developmentally silenced globin genes by forced chromatin looping (2014) · cites this paper as Sankaran et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evo-Devo and an Expanding Evolutionary Synthesis: A Genetic Theory of Morphological Evolution
Carroll, S. B. (2008) · Cell · doi:10.1016/j.cell.2008.06.030 · Cited by 2,067
THE LOCUS OF EVOLUTION: EVO DEVO AND THE GENETICS OF ADAPTATION
Hoekstra, H. E., & Coyne, J. A. (2007) · Evolution · doi:10.1111/j.1558-5646.2007.00105.x · Cited by 976
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Self-citationUda, M., Galanello, R., Sanna, S., Lettre, G., Sankaran, V. G., Chen, W., Usala, G., Busonero, F., Maschio, A., Albai, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711566105 · Cited by 672
Self-citationLettre, G., Sankaran, V. G., Bezerra, M. A. C., Araújo, A. S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F. F., Hirschhorn, J. N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804799105 · Cited by 561
Self-citationA QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2108 · Cited by 529
Transcription complex stability and chromatin dynamics in vivo
Wijgerde, M., Grosveld, F., & Fraser, P. (1995) · Nature · doi:10.1038/377209a0 · Cited by 471
Zhang, J., Socolovsky, M., Gross, A. W., & Lodish, H. F. (2003) · Blood · doi:10.1182/blood-2003-05-1479 · Cited by 386
Bcl11a is essential for normal lymphoid development
Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G. (2003) · Nature Immunology · doi:10.1038/ni925 · Cited by 351
Ragoczy, T., Bender, M. A., Telling, A., Byron, R., & Groudine, M. (2006) · Genes & Development · doi:10.1101/gad.1419506 · Cited by 329
Self-citation
Cited by
Items 101–200 of 417
Cánovas, J., Berndt, F. A., Sepúlveda, H., Aguilar, R., Veloso, F. A., Montecino, M., Oliva, C., Maass, J. C., Sierralta, J., & Kukuljan, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0169-15.2015 · Cited by 63
“The function of CTIP1 has been well characterized in lymphoid and dendritic cells development and erythrocyte differentiation (Liu et al., 2003; Sankaran et al., 2008, 2009, 2010; Jawaid et al., 2010; Xu et al., 2010; Yu et al., 2012; Wu et al., 2013).”
BackgroundBenitez, C. M., Qu, K., Sugiyama, T., Pauerstein, P. T., Liu, Y., Tsai, J., Gu, X., Ghodasara, A., Arda, H. E., Zhang, J., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004645 · Cited by 56
Reactivation of a developmentally silenced embryonic globin gene
King, A. J., Songdej, D., Downes, D. J., Beagrie, R. A., Liu, S., Buckley, M., Peng, H., Suciu, M., Oudelaar, A. M., Hanssen, L. L. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24402-3 · Cited by 62
Self-citationEvolution of transcriptional control in mammals
Wilson, M. D., & Odom, D. T. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.003 · Cited by 62
Bjurström, C. F., Mojadidi, M., Phillips, J., Kuo, C., Lai, S., Lill, G. R., Cooper, A., Kaufman, M., Urbinati, F., Wang, X., et al. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.52 · Cited by 55
Customizing the genome as therapy for the β-hemoglobinopathies.
Canver, M. C., & Orkin, S. H. (2016) · Blood · doi:10.1182/blood-2016-01-678128 · Cited by 61
Self-citationKim, Y. J., Lee, M., Lee, Y., Ji, J., Sanders, J. T., Botten, G. A., He, L., Lyu, J., Zhang, Y., Mettlen, M., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg1123 · Cited by 61
Self-citationKojo, S., Tanaka, H., Endo, T. A., Muroi, S., Liu, Y., Seo, W., Tenno, M., Kakugawa, K., Naoe, Y., Nair, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00768-1 · Cited by 60
Kiefer, C. M., Lee, J., Hou, C., Dale, R. K., Lee, Y. T., Meier, E. R., Miller, J. L., & Dean, A. (2011) · Blood · doi:10.1182/blood-2011-06-363101 · Cited by 59
Jiang, B., Zhang, X., Su, J., Meng, W., Yang, X., Yang, J., Zhou, Q., Chen, Z., Chen, Z., Xie, Z., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-61 · Cited by 59
Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice
Esteghamat, F., Gillemans, N., Bilic, I., van den Akker, E., Cantù, I., van Gent, T., Klingmüller, U., van Lom, K., von Lindern, M., Grosveld, F., et al. (2013) · Blood · doi:10.1182/blood-2012-06-434530 · Cited by 51
Erythroid development in the mammalian embryo
Baron, M. H., Vacaru, A. M., & Nieves, J. L. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.07.006 · Cited by 58
Fujita, A., Uchida, N., Haro‐Mora, J. J., Winkler, T., & Tisdale, J. F. (2016) · Stem Cells · doi:10.1002/stem.2335 · Cited by 57
Discovering human diabetes-risk gene function with genetics and physiological assays
Peiris, H. S., Park, S., Louis, S., Gu, X., Lam, J. Y., Asplund, O., Ippolito, G. C., Bottino, R., Groop, L., Tucker, H. O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06249-3 · Cited by 58
Self-citationRole of the GATA-1/FOG-1/NuRD Pathway in the Expression of Human β-Like Globin Genes
Miccio, A., & Blobel, G. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00001-10 · Cited by 46
Erlandsson, L., Masoumi, Z. T., Hansson, L. R., & Hansson, S. R. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13349 · Cited by 56
Ulirsch, J. C., Lacy, J. N., An, X., Mohandas, N., Mikkelsen, T. S., & Sankaran, V. G. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004890 · Cited by 48
Self-citationSpecies-wide genomics of kākāpō provides tools to accelerate recovery
Guhlin, J. G., Lec, M. F. L., Wold, J., Koot, E. M., Winter, D. J., Biggs, P. J., Galla, S. J., Urban, L., Foster, Y., Cox, M. P., et al. (2023) · Nature Ecology & Evolution · doi:10.1038/s41559-023-02165-y · Cited by 57
Smarca5-mediated epigenetic programming facilitates fetal HSPC development in vertebrates
Ding, Y., Wang, W., Ma, D., Liang, G., Kang, Z., Xue, Y., Zhang, Y., Wang, L., Heng, J., Zhang, Y., et al. (2020) · Blood · doi:10.1182/blood.2020005219 · Cited by 54
Funnell, A. P. W., Mak, K. S., Twine, N. A., Pelka, G. J., Norton, L. J., Radziewic, T., Power, M., Wilkins, M. R., Bell-Anderson, K. S., Fraser, S. T., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00074-13 · Cited by 54
Synthesis of 53 tissue and cell line expression QTL datasets reveals master eQTLs
Zhang, X., Gierman, H. J., Levy, D., Plump, A., Dobrin, R., Goring, H. H., Curran, J. E., Johnson, M. P., Blangero, J., Kim, S. K., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-532 · Cited by 49
Recent Advances in β-Thalassemias
Cao, A., Moi, P., & Galanello, R. (2011) · Pediatric Reports · doi:10.4081/pr.2011.e17 · Cited by 53
Strict in vivo specificity of the Bcl11a erythroid enhancer
Smith, E. C., Luc, S., Croney, D. M., Woodworth, M. B., Greig, L. C., Fujiwara, Y., Nguyen, M., Sher, F., Macklis, J. D., Bauer, D. E., et al. (2016) · Blood · doi:10.1182/blood-2016-08-736249 · Cited by 48
Self-citationRegulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis
Kim, M. Y., Yan, B., Huang, S., & Qiu, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228460 · Cited by 52
Chi, K. R. (2009) · Nature · doi:10.1038/461712a · Cited by 52
Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation
Bottardi, S., Zmiri, F. A., Bourgoin, V., Ross, J., Mavoungou, L., & Milot, E. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1271 · Cited by 40
Genetic disruption of the KLF1 gene to overexpress the γ‐globin gene using the CRISPR/Cas9 system
Shariati, L., Khanahmad, H., Salehi, M., Hejazi, Z., Rahimmanesh, I., Tabatabaiefar, M. A., & Modarressi, M. H. (2016) · The Journal of Gene Medicine · doi:10.1002/jgm.2928 · Cited by 51
Reversing the Hemoglobin Switch
Sankaran, V. G., & Nathan, D. G. (2010) · New England Journal of Medicine · doi:10.1056/nejmcibr1010767 · Cited by 50
Self-citationTranscriptional Mechanisms Underlying Hemoglobin Synthesis
Katsumura, K. R., DeVilbiss, A., Pope, N. J., Johnson, K. D., & Bresnick, E. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015412 · Cited by 50
The genetics of human hematopoiesis and its disruption in disease
Bao, E. L., Cheng, A. N., & Sankaran, V. G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910316 · Cited by 42
Self-citationGenetic modifiers of HbF and response to hydroxyurea in sickle cell disease
Green, N., & Barral, S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22754 · Cited by 50
Hemoglobin genetics: recent contributions of GWAS and gene editing
Smith, E. C., & Orkin, S. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw170 · Cited by 45
Self-citationMicroRNAs as regulators and effectors of hematopoietic transcription factors
Kim, M., Civin, C. I., & Kingsbury, T. J. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1537 · Cited by 48
Banan, M., Bayat, H., Azarkeivan, A., Mohammadparast, S., Kamali, K., Farashi, S., Bayat, N., Khani, M. H., Neishabury, M., & Najmabadi, H. (2012) · Hemoglobin · doi:10.3109/03630269.2012.691147 · Cited by 48
CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications
Ebrahimi, S., Khosravi, M. A., Raz, A., Karimipoor, M., & Parvizi, P. (2023) · ̒Ulūm va funūn-i bastah/bandī · doi:10.61186/ibj.27.5.219 · Cited by 48
Whole genome association studies in complex diseases: where do we stand?
Need, A. C., & Goldstein, D. B. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/aneed · Cited by 40
Leung, A., Zulick, E., Skvir, N. J., Vanuytsel, K., Morrison, T. A., Naing, Z. H., Wang, Z., Dai, Y., Chui, D. H. K., Steinberg, M. H., et al. (2018) · Stem Cells · doi:10.1002/stem.2822 · Cited by 49
Mohammadparast, S., Bayat, H., Biglarian, A., & Ohadi, M. (2014) · American Journal of Primatology · doi:10.1002/ajp.22266 · Cited by 46
Role of ZBP-89 in human globin gene regulation and erythroid differentiation
Woo, A. J., Kim, J., Xu, J., Huang, H., & Cantor, A. B. (2011) · Blood · doi:10.1182/blood-2011-03-341446 · Cited by 46
Self-citationDubuissez, M., Loison, I., Paget, S., Vorng, H., Yahia, S. A., Rohr, O., Tsicopoulos, A., & Leprince, D. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00062-16 · Cited by 46
Sickle Cell Disease at 100 Years
Orkin, S. H., & Higgs, D. R. (2010) · Science · doi:10.1126/science.1194035 · Cited by 46
Self-citationHuman fetal globin gene expression is regulated by LYAR
Ju, J., Wang, Y., Liu, R., Zhang, Y., Xu, Z., Wang, Y., Wu, Y.-P., Liu, M., Cerruti, L., Zou, F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku718 · Cited by 45
The Association ofCD81Polymorphisms with Alloimmunization in Sickle Cell Disease
Tatari-Calderone, Z., Tamouza, R., Bouder, G. P. L., Dewan, R., Luban, N. L. C., Lasserre, J., Maury, J., Lionnet, F., Krishnamoorthy, R., Girot, R., et al. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/937846 · Cited by 44
Chou, Y., Chen, R.-L., Lai, Z.-S., Song, J., Chao, Y., & Shen, C.-K. J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00035-15 · Cited by 42
Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression
Zhu, J., Chin, K., Aerbajinai, W., Kumkhaek, C., Li, H., & Rodgers, G. P. (2014) · Blood · doi:10.1182/blood-2013-10-534842 · Cited by 41
Genetic therapies for sickle cell disease
Esrick, E. B., & Bauer, D. E. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.014 · Cited by 41
Khandros, E., Huang, P., Peslak, S. A., Sharma, M., Abdulmalik, O., Giardine, B. M., Zhang, Z., Keller, C. A., Hardison, R. C., & Blobel, G. A. (2020) · Blood · doi:10.1182/blood.2020005058 · Cited by 40
Modifier genes in Mendelian disorders: the example of hemoglobin disorders
Sankaran, V. G., Lettre, G., Orkin, S. H., & Hirschhorn, J. N. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05821.x · Cited by 40
Self-citationTargeted Fetal Hemoglobin Induction for Treatment of Beta Hemoglobinopathies
Perrine, S. P., Pace, B. S., & Faller, D. V. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.009 · Cited by 40
Pereira, C., Relvas, L., Bento, C., Abade, A., Ribeiro, L., & Manco, L. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.02.001 · Cited by 40
Disruption of the Hbs1l-Myb Locus Causes Hereditary Persistence of Fetal Hemoglobin in a Mouse Model
Suzuki, M., Yamazaki, H., Mukai, H. Y., Motohashi, H., Shi, L., Tanabe, O., Engel, J. D., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01617-12 · Cited by 40
Pharmacological and molecular approaches for the treatment of β‐hemoglobin disorders
Lohani, N., Bhargava, N., Munshi, A., & Ramalingam, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26292 · Cited by 40
King, A. J., & Higgs, D. R. (2018) · Hematology · doi:10.1182/asheducation-2018.1.353 · Cited by 40
Fucharoen, S., Inati, A. C., Siritanaratku, N., Thein, S. L., Wargin, W. C., Koussa, S., Taher, A. T., Chaneim, N., Boosalis, M. S., BERENSON, R. J., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12304 · Cited by 39
Genome-wide association studies of hematologic phenotypes: a window into human hematopoiesis
Sankaran, V. G., & Orkin, S. H. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.02.006 · Cited by 33
Self-citationMoleirinho, A., Seixas, S., Lopes, A. M., Bento, C., Prata, M. J., & Amorim, A. (2013) · Genome Biology and Evolution · doi:10.1093/gbe/evt029 · Cited by 39
Gudmundsdottir, B., Gudmundsson, K. O., Klarmann, K. D., Singh, S. K., Sun, L., Singh, S., Du, Y., Coppola, V., Stockwin, L. H., Nguyen, N., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.043 · Cited by 38
From Genetic Association to Molecular Mechanism
van de Bunt, M., & Gloyn, A. L. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0150-2 · Cited by 37
Shariati, L., Rohani, F., Hafshejani, N. H., Kouhpayeh, S., Boshtam, M., Mirian, M., Rahimmanesh, I., Hejazi, Z., Modarres, M., Pieper, I. L., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27253 · Cited by 37
Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Zakaria, N. A., Islam, M. A., Abdullah, W. Z., Bahar, R., Yusoff, A. A. M., Wahab, R. A., Shamsuddin, S., & Johan, M. F. (2021) · Biomolecules · doi:10.3390/biom11050755 · Cited by 37
BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes
Sunami, Y., Yokoyama, T., Yoshino, S., Takahara, T., Yamazaki, Y., Harada, H., & Nakamura, T. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004558 · Cited by 37
Krüppel-Like Factor 1: A Pivotal Gene Regulator in Erythropoiesis
Caria, C. A., Faà, V., & Ristaldi, M. S. (2022) · Cells · doi:10.3390/cells11193069 · Cited by 37
Animal models of β-hemoglobinopathies: utility and limitations
McColl, B., & Vadolas, J. (2016) · Journal of Blood Medicine · doi:10.2147/jbm.s87955 · Cited by 37
Genome Editing for β-Hemoglobinopathies: Advances and Challenges
Frati, G., & Miccio, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030482 · Cited by 36
Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials
Segura, E., Ayoub, P. G., Hart, K. L., & Kohn, D. B. (2023) · Viruses · doi:10.3390/v15030713 · Cited by 35
Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
Paschoudi, K., Yannaki, E., & Psatha, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119527 · Cited by 34
Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes
Martin-Rufino, J. D., Caulier, A., Lee, S., Castano, N., King, E., Joubran, S. R., Jones, M. K., Goldman, S. R., Arora, U. P., Wahlster, L., et al. (2025) · Science · doi:10.1126/science.ads7951 · Cited by 33
Self-citationGenome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies
Demirci, S., Leonard, A. K., & Tisdale, J. F. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa088 · Cited by 33
Guo, X., Plank-Bazinet, J. L., Krivega, I. V., Dale, R., & Dean, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa736 · Cited by 32
Studying the altered timing of physiological events during development: It's about time…or is it?
Spicer, J. I., Rundle, S. D., & Tills, O. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.06.005 · Cited by 32
Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?
Banan, M. (2013) · Annals of Hematology · doi:10.1007/s00277-012-1671-3 · Cited by 34
Lee, B.-S., Lee, B., Iyer, V. R., Sleckman, B. P., Shaffer, A. L., Ippolito, G. C., Tucker, H. O., & Dekker, J. D. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00362-17 · Cited by 32
Self-citationChambers, C. B., Gross, J., Pratt, K. L., Guo, X., Byrnes, C., Lee, Y. T., Lavelle, D., Dean, A., Miller, J. L., & Wilber, A. C. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.01.011 · Cited by 32
Fetal globin gene inducers: novel agents and new potential
Perrine, S. P., Castañeda, S. A., Chui, D. H. K., Faller, D. V., BERENSON, R. J., Siritanaratku, N., & Fucharoen, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05593.x · Cited by 31
Katayama, K., Ishii, K. J., Terashima, H., Tsuda, E., Suzuki, M., Yotsumoto, K., Hiramoto, K., Yasumatsu, I., Torihata, M., Ishiyama, T., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00572 · Cited by 32
Erythropoiesis: insights from a genomic perspective
Ji, H. Y. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01311-1 · Cited by 30
Cellular Basis of Embryonic Hematopoiesis and Its Implications in Prenatal Erythropoiesis
Yamane, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249346 · Cited by 30
Evolution of nanobodies specific for BCL11A
Yin, M., Izadi, M., Tenglin, K., Viennet, T., Zhai, L., Zheng, G., Arthanari, H., Dassama, L. M. K., & Orkin, S. H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218959120 · Cited by 30
Self-citationFetal Hemoglobin Regulation in Beta-Thalassemia
Lu, H. Y., Orkin, S. H., & Sankaran, V. G. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.002 · Cited by 30
Self-citationFanis, P., Kousiappa, I., Phylactides, M., & Kleanthous, M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-108 · Cited by 31
Diagnosis and prevention of thalassemia
Ip, H., & So, C. C. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.847236 · Cited by 30
Correction of Beta-Thalassemia IVS-II-654 Mutation in a Mouse Model Using Prime Editing
Zhang, H., Sun, R., Fei, J., Chen, H., & Lu, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115948 · Cited by 30
Functional analysis of erythrocyte determinants of Plasmodium infection
Bei, A. K., & Duraisingh, M. T. (2012) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.03.006 · Cited by 29
Histone Deacetylase 9 Activates γ-Globin Gene Expression in Primary Erythroid Cells
Muralidhar, S. A., Ramakrishnan, V., Kalra, I. S., Li, W., & Pace, B. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115725 · Cited by 29
Ali, G., Tariq, M. A., Shahid, K., Ahmad, F. J., & Akram, J. (2020) · Gene Therapy · doi:10.1038/s41434-020-0153-9 · Cited by 30
Future alternative therapies for β-thalassemia
Rivella, S., & Rachmilewitz, E. A. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.56 · Cited by 29
Abnormal regulation of microRNAs and related genes in pediatric β‐thalassemia
Wang, H., Chen, M., Xu, S., Pan, Y., Zhang, Y., Huang, H., & Xu, L. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23945 · Cited by 28
Chaouch, L., Moumni, I., Ouragini, H., Darragi, I., Kalai, M., Chaouachi, D., Boudrigua, I., Hafsia, R., & Abbès, S. (2015) · Hematology · doi:10.1080/10245332.2015.1107275 · Cited by 28
Ochi, K., Takayama, N., Hirose, S.-I., Nakahata, T., Nakauchi, H., & Eto, K. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0216 · Cited by 28
Chan, C. M., Fulton, J., Montiel‐Duarte, C., Collins, H. M., Bharti, N., Wadelin, F. R., Moran, P. M., Mongan, N. P., & Heery, D. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt761 · Cited by 28
Putting a finger on the switch
Bieker, J. J. (2010) · Nature Genetics · doi:10.1038/ng0910-733 · Cited by 27
Transcriptome dynamics during human erythroid differentiation and development
Yang, Y., Wang, H., Chang, K., Qu, H., Zhang, Z., Xiong, Q., Qi, H., Cui, P., Lin, Q., Ruan, X., et al. (2013) · Genomics · doi:10.1016/j.ygeno.2013.09.005 · Cited by 27
Bhanushali, A. A., Patra, P. K., Nair, D., Verma, H. K., & Das, B. R. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.10.003 · Cited by 26
Advances in therapeutic application of CRISPR-Cas9
Sun, J., Wang, J., Zheng, D., & Hu, X. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz031 · Cited by 26
Li, Y., Ding, L., Li, W., Story, M. D., & Pace, B. S. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-153 · Cited by 26
Sun, K., Huang, Y., Palanisamy, K., Chang, S., Wang, I., Wu, K., Chen, P., Peng, C., & Li, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-00150-7 · Cited by 26
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 25
Erythropoiesis in the mammalian embryo
Palis, J. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104283 · Cited by 25
Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease
Cui, S., & Engel, J. D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_7 · Cited by 25
Rogers, J. M., & Bulyk, M. L. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1423 · Cited by 25
Metadata
- Authors
- Sankaran, V. G., Xu, J., Ragoczy, T., Ippolito, G. C., Walkley, C. R., Maika, S. D., Fujiwara, Y., Ito, M., Groudine, M., Bender, M. A., Tucker, P. W., & Orkin, S. H.
- Affiliations
- Boston Children's Hospital (US)
- Fred Hutch Cancer Center (US)
- The University of Texas at Austin (US)
- Japanese Red Cross Nagoya Daiichi Hospital (JP)
- University of Washington (US)
- Corresponding author
- Orkin, Stuart H.
- ORCID
- Venue
- Nature
- Published
- 2009-08
- Volume
- 460
- Issue
- 7259
- Pages
- 1093-1097
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3749913
- OpenAlex
- W1979216961
- Semantic Scholar
- def695b9f66914c7440b8110c4844749cf777dfb
- Cited by
- 379
- References
- 38
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 18 · 2023: 16 · 2022: 13 · 2021: 20 · 2020: 28 · 2019: 15 · 2018: 24 · 2017: 24 · 2016: 39 · 2015: 20 · 2014: 24 · 2013: 33 · 2012: 19
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (P01HL032262)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- BCL11A, globin switching, beta-globin locus, gamma-globin, embryonic globin, trans-acting factors, gene regulatory evolution, transgenic mice, cis-regulatory elements
- MeSH terms
- Animals, Carrier Proteins, DNA-Binding Proteins, Embryo, Mammalian, Fetus, Globins, Hematopoiesis, Humans, Nuclear Proteins, Repressor Proteins, Species Specificity, Gene Expression Regulation, Developmental, Evolution, Molecular, Gene Silencing, Mice, beta-Globins, gamma-Globins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.